암
Early University of Calgary trial tests high-dose niacin as add-on treatment for glioblastoma
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
Researchers at the University of Calgary are studying whether high doses of vitamin B3 (niacin) can improve outcomes for patients with newly diagnosed glioblastoma when added to standard treatment. An interim analysis of 24 patients found a higher-than-expected six‑month progression‑free survival rate, though investigators stress the results are preliminary and require ongoing safety monitoring.
Researchers have used genetically modified phages to harness pre-existing vaccine immunity and destroy cancer cells in mice. The approach eradicated tumors in 44 percent of treated animals with no recurrence after a year.
AI에 의해 보고됨
A study has identified how an existing medication could improve immunotherapy outcomes for fibrolamellar carcinoma. The rare liver cancer currently has no cure and often spreads before detection. Researchers demonstrated the approach using patient tumor samples.
A Phase II randomized trial found that a six-week, home-based walking and resistance program improved attention test performance and reduced reports that others noticed cognitive problems among patients receiving chemotherapy. Low-dose ibuprofen improved some attention measures but showed mixed results on memory outcomes. The study was published in Cancer.
AI에 의해 보고됨
지난 20년간 홍콩 여성의 폐암 신규 발병 사례가 20% 증가했습니다. 전문가들은 흡연 외에도 유전적 요인과 조리 시 발생하는 연기가 주요 원인이라고 지적합니다.
홍콩의 암 발병 건수는 1983년 이후 두 배 이상 증가했으나, 연령 표준화 사망률은 2023년 인구 10만 명당 71.1명으로 절반 가까이 감소했다.
AI에 의해 보고됨
New research from Fox Chase Cancer Center shows that melanoma spreads more aggressively in middle-aged mice than in young or very old ones. The pattern appears linked to changes in a specific type of immune cell over time.
Three patients receive cancer-detecting brain implants
2026년 06월 21일 12시 32분Review finds nicotine e-cigarettes likely to cause lung and oral cancers, but precise risks remain unclear
2026년 06월 20일 12시 05분Study finds excessive EXO1 DNA-repair activity can destabilize genomes and may mark tumors sensitive to some therapies
2026년 06월 18일 16시 29분온코리스 대표가 밝히는 세계 최초 암 치료제 개발 여정
2026년 06월 12일 21시 46분Second report on Oncology Alert Plan shows 99.9% of patients contacted
2026년 06월 06일 09시 59분Study links GLP-1 drugs to lower breast cancer risk
2026년 06월 05일 13시 36분CRIS Cancer to donate 3.6 million to Vega Oncotargets after controversy
2026년 06월 04일 23시 56분New drug Daraxonrasib nearly doubles survival in pancreatic cancer trial
2026년 06월 04일 18시 22분Princess of Wales hugs cancer survivor at Manchester hospital
2026년 06월 01일 12시 17분Thymus health may predict longevity and cancer outcomes